🕵️ Engene Therapeutics Inc. ($ENGN)
SEC insider & ownership activity, last 12 months · CIK 1980845 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. BML Investment Partners, L.P. added 7.8% → 9.9%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Joseph Edelman | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| BML Investment Partners, L.P. | 9.9% | 13G | May 14, 2026 | filing ↗ | |
| Bong Y. Koh | 9.9% | 13G | Feb 14, 2025 | filing ↗ | |
| Raymond Debbane | 9.3% | 13G | Aug 13, 2026 | filing ↗ | |
| Invus Public Equities, L.P. | 8.2% | 13G | Aug 13, 2026 | filing ↗ | |
| Invus Public Equities Advisors, LLC | 8.2% | 13G | Aug 13, 2026 | filing ↗ | |
| Invus Global Management, LLC | 8.2% | 13G | Aug 13, 2026 | filing ↗ | |
| Siren, L.L.C. | 8.2% | 13G | Aug 13, 2026 | filing ↗ | |
| Anders Hove | 5.0% | 13G | Jul 22, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Sep 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 8, 2026 | filing ↗ |
| Other events (8.01) | Aug 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 15, 2026 | filing ↗ |
| Exit or disposal costs (2.05) | Jun 16, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 16, 2026 | filing ↗ |
| Earnings (2.02) | Jun 13, 2026 | filing ↗ |
| Exit or disposal costs (2.05) | Jun 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 13, 2026 | filing ↗ |
| Other events (8.01) | Jun 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 13, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 5, 2026 | filing ↗ |
| Other events (8.01) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 7, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 9, 2026 | filing ↗ |
| Agreement terminated (1.02) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Earnings (2.02) | Mar 9, 2026 | filing ↗ |